Rx (Prescription Medicine)
USD $ 607.00
Hermab 150mg 注射液是一种含有活性成分 Trastuzumab 的药品。Trastuzumab 是一种靶向治疗药物，具体来说是一种单克隆抗体，用于治疗某些类型的癌症。它通过靶向 HER2（人类表皮生长因子受体 2）蛋白来发挥作用，该蛋白在某些癌细胞（包括部分乳腺癌和胃癌）中过表达。通过与 HER2 结合，Trastuzumab 抑制这些癌细胞的生长和增殖。
Hermab 150mg 注射液适用于 HER2 阳性乳腺癌的治疗，无论是早期还是晚期，以及 HER2 阳性转移性胃癌或胃食管交界部腺癌。Hermab 150mg 注射液的剂量和给药方式应由合格的医疗专业人员根据患者的病情和对治疗的反应来决定。常见的不良反应可能包括发热、寒颤、恶心、呕吐、疲劳以及输液相关反应。严重的不良反应也可能发生，患者应立即向医生报告任何不寻常的症状。Hermab 150mg 注射液应按照制造商的说明进行保存，通常需要冷藏并避光保存。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Pack Quantity | |
| Brand Name | |
| Strength |
其他品牌的 Trastuzumab 150 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
